Nalaganje...

Medical and developmental outcomes of bevacizumab versus laser for retinopathy of prematurity

BACKGROUND: Infants with stage 3+ retinopathy of prematurity (ROP) in zone I or zone II posterior were randomized to initial treatment with bevacizumab or laser in a multicenter trial (BEAT-ROP). The purpose of this study was to assess the effects of bevacizumab on nonophthalmologic outcomes. METHOD...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J AAPOS
Main Authors: Kennedy, Kathleen A., Mintz-Hittner, Helen A.
Format: Artigo
Jezik:Inglês
Izdano: 2017
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5826862/
https://ncbi.nlm.nih.gov/pubmed/29223789
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaapos.2017.10.006
Oznake: Označite
Brez oznak, prvi označite!